Biomarin Pharmaceutical (BMRN) Operating Margin Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,993.00 |
| 10 | Biomarin Pharmaceutical | 11.71 Bn | 9.49 Bn | 571.21 Mn | 646.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 646.00 |
| Dec 31, 2025 | -267.00 |
| Sep 30, 2025 | -554.00 |
| Jun 30, 2025 | 2,621.00 |
| Mar 31, 2025 | 361.00 |
| Dec 31, 2024 | 3,624.00 |
| Sep 30, 2024 | 2,829.00 |
| Jun 30, 2024 | 1,459.00 |
| Mar 31, 2024 | 847.00 |
| Dec 31, 2023 | 1,562.00 |
| Sep 30, 2023 | 1,698.00 |
| Jun 30, 2023 | 2,055.00 |
| Mar 31, 2023 | -1,044.00 |
| Dec 31, 2022 | -42.00 |
| Sep 30, 2022 | -135.00 |
| Jun 30, 2022 | 1,800.00 |
| Mar 31, 2022 | 3,990.00 |
| Dec 31, 2021 | -385.00 |
| Sep 30, 2021 | -900.00 |
| Jun 30, 2021 | 910.00 |